Papers matching “essential thrombocythemia” 67
Not finding it? Sign in to also search OpenAlex live.
-
Clinicohematologic and molecular response of essential thrombocythemia patients treated with pegylated interferon-α: a multi-center study of the German Study Group-Myeloproliferative Neoplasms (GSG-MPN)
Frank Stegelmann, Lino Lars Teichmann, Florian Heinrich Heidel, Carl C. Crodel, Thomas Ernst, Sebastian Kreil, +11 more
8citations -
Among classic myeloproliferative neoplasms, essential thrombocythemia is associated with the greatest risk of venous thromboembolism during COVID-192021 Blood Cancer Journal article Medicine Myeloproliferative Neoplasms: Diagnosis and Treatment Open access
Tiziano Barbui, Valerio De Stefano, Alberto Álvarez‐Larrán, Alessandra Iurlo, Arianna Masciulli, Alessandra Carobbio, +43 more
37citations -
ROP-ET: a prospective phase III trial investigating the efficacy and safety of ropeginterferon alfa-2b in essential thrombocythemia patients with limited treatment options2024 Annals of Hematology article Medicine Myeloproliferative Neoplasms: Diagnosis and Treatment Open access
Jean‐Jacques Kiladjian, Francisca Ferrer‐Marín, Haifa Kathrin Al‐Ali, Alberto Álvarez‐Larrán, Eloise Beggiato, Maria Bieniaszewska, +35 more
16citations -
Safety and efficacy of INCA033989, a novel first in class mutant calreticulin-specific monoclonal antibody, in patients with essential thrombocythemia2025 Blood conference-abstract Medicine Myeloproliferative Neoplasms: Diagnosis and Treatment Open access
Vikas Gupta, John O Mascarenhas, Haris Ali, David M. Ross, Abdulraheem Yacoub, Tania Jain, +27 more
10citations -
Ruxolitinib Versus Best Available Therapy in Patients with Essential Thrombocythemia: Pre-Specified Interim Analysis of the Randomized Phase 2b Ruxobeat Clinical Trial of the German Study Group for Myeloproliferative Neoplasms (GSG-MPN)
Steffen Koschmieder, Susanne Isfort, Florian Heinrich Heidel, Andreas Hochhaus, Heiko Becker, Philipp Jakob Jost, +19 more
3citations -
A Phase 3, Randomized, Double-Blind, Active-Comparator-Controlled Study of Bomedemstat Versus Hydroxyurea in Patients with Essential Thrombocythemia Naïve to Cytoreductive Therapy2024 Blood conference-abstract Medicine Myeloproliferative Neoplasms: Diagnosis and Treatment Open access
Yuka Sugimoto, Eran Zimran, Yoshimitsu Shimomura, Hiroki Yamaguchi, Hans Carl Hasselbach, Jean‐Jacques Kiladjian, +14 more
2citations -
Clinicohematologic and Molecular Response of Essential Thrombocythemia Patients Treated with Pegylated Interferon-Alpha: A Multicenter Study on Behalf of the German Study Group-MPN (GSG-MPN)
Frank Stegelmann, Lino Lars Teichmann, Florian Heinrich Heidel, Carl C. Crodel, Thomas Ernst, Sebastian Kreil, +11 more
0citations -
Shorespan-007: Phase 3 study of bomedemstat versus hydroxyurea in essential thrombocythemia naive to cytoreductive therapy.2025 Journal of Clinical Oncology conference-abstract Medicine Myeloproliferative Neoplasms: Diagnosis and Treatment Open access
Kristen Marie Pettit, Yuka Sugimoto, Eran Zimran, Yoshimitsu Shimomura, Hiroki Yamaguchi, Hans Carl Hasselbach, +14 more
0citations -
ROP-ET: A Prospective Phase III Trial Investigating the Efficacy and Safety of Ropeginterferon Alfa-2b in Essential Thrombocythemia Patients with Limited Treatment Options
Jean‐Jacques Kiladjian, Francisca Ferrer‐Marín, Haifa Kathrin Al‐Ali, Alberto Álvarez‐Larrán, Eloise Beggiato, Maria Bieniaszewska, +35 more
0citations -
MPN-481: Mutant Calreticulin-Specific Monoclonal Antibody, INCA033989, is Well Tolerated and Achieves Rapid and Sustained Hematologic and Molecular Responses in Patients With Essential Thrombocythemia2026 Clinical Lymphoma Myeloma & Leukemia conference-abstract Medicine Myeloproliferative Neoplasms: Diagnosis and Treatment
Haris Ali, Tania Jain, Aaron Thomas Gerds, Vikas Gupta, Claire N. Harrison, Joan How, +27 more
0citations -
POSTER: MPN-481: Mutant Calreticulin-Specific Monoclonal Antibody, INCA033989, is Well Tolerated and Achieves Rapid and Sustained Hematologic and Molecular Responses in Patients With Essential Thrombocythemia2026 Clinical Lymphoma Myeloma & Leukemia article Medicine Myeloproliferative Neoplasms: Diagnosis and Treatment
Haris Ali, Tania Jain, Aaron Thomas Gerds, Vikas Gupta, Claire N. Harrison, Joan How, +27 more
0citations -
Progression of Myeloproliferative Neoplasms (MPN): Diagnostic and Therapeutic Perspectives2021 Cells article Medicine Myeloproliferative Neoplasms: Diagnosis and Treatment Open access cited by 1 patent
Julian Baumeister, Nicolas Chatain, Alexandros Marios Sofias, Twan Lammers, Steffen Koschmieder
87citations -
Therapeutic Cancer Vaccination With a Peptide Derived From the Calreticulin Exon 9 Mutations Induces Strong Cellular Immune Responses in Patients With CALR-Mutant Chronic Myeloproliferative Neoplasms2021 Frontiers in Oncology article Immunology and Microbiology Immunotherapy and Immune Responses Open access cited by 1 patent
Jacob Handlos Grauslund, Morten Orebo Holmström, Nicolai Grønne Dahlager Jørgensen, Uffe Klausen, Stine Emilie Weis-Banke, Daniel El Fassi, +16 more
59citations -
Early and late stage MPN patients show distinct gene expression profiles in CD34+ cells2021 Annals of Hematology article Medicine Myeloproliferative Neoplasms: Diagnosis and Treatment Open access
Julian Baumeister, Tiago Maié, Nicolas Chatain, Barbora Weinbergerová, Marcelo A. S. Toledo, Jörg Eschweiler, +9 more
24citations -
Macrophage frequency in the bone marrow correlates with morphologic subtype of myeloproliferative neoplasm2020 Annals of Hematology article Medicine Myeloproliferative Neoplasms: Diagnosis and Treatment Open access
David C. A. Molitor, Peter Boor, Andreas Buneß, Rebekka K. Schneider, Lino Lars Teichmann, Ruth-Miriam Körber, +3 more
18citations -
Germline variants in DNA repair genes, including BRCA1/2, may cause familial myeloproliferative neoplasms2021 Blood Advances article Medicine Myeloproliferative Neoplasms: Diagnosis and Treatment Open access
Miriam Elbracht, Robert Meyer, Kim Kricheldorf, Deniz Gezer, Thomas Eggermann, Beate Betz, +6 more
17citations -
The telomerase inhibitor imetelstat differentially targets JAK2V617F versus CALR mutant myeloproliferative neoplasm cells and inhibits JAK-STAT signaling2023 Frontiers in Oncology article Medicine Myeloproliferative Neoplasms: Diagnosis and Treatment Open access
Kathrin Olschok, Bianca Altenburg, Marcelo A. S. Toledo, Angela Maurer, Anne Abels, Fabian Beier, +7 more
15citations